查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986325

全球獸藥市場：市場規模、佔有率和趨勢分析（按產品、動物類型、給藥途徑、劑型和地區分類），細分市場預測（2026-2033 年）

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route of Administration, By Dosage Form, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

動物藥品市場概述

2025年全球動物藥品市場規模估計為16.8億美元，預計2033年將達32.5億美元。

預計從 2026 年到 2033 年，該市場將以 8.52% 的複合年成長率成長。市場擴張的原因是人們對個人化獸醫藥物的需求不斷成長，市售動物用藥品短缺和停產，以及寵物飼養量和獸醫保健支出不斷增加。

隨著獸醫學的日益複雜，對能夠滿足動物多樣化需求的個人化藥物製劑的需求也日益成長。標準化藥物往往無法提供準確的劑量、適當的給藥途徑或令人滿意的偏好。此外，配製藥物使獸醫能夠調整藥物的療效、配方、輔料和口味，從而提高遵守用藥和治療效果。個人化治療方法對於小型哺乳動物、老年動物以及需要長期治療的慢性疾病病例尤其重要。配製藥物還可以根據不同物種的需求，製成調味懸浮液、微劑量膠囊或經皮凝膠等劑型。

此外，持續的供應中斷和動物用藥品停產使得獸醫更加依賴配製藥物來維持治療的連續性。由於需求疲軟、生產難題或監管變化導致的市場退出，常常造成治療缺口，尤其對於一些特殊物種和特定疾病而言更是如此。此外，獸藥配製使藥劑師能夠重新配製停產藥物並製備替代療法，從而確保患者能夠不間斷地獲得必要的治療。這對於慢性病、老年動物以及市售替代藥物有限的特殊治療尤其重要。此外，供應鏈不穩定、原料短缺以及生產重點的轉變，使得配製藥物成為至關重要的支持體系，尤其對於藥物供應有限的當地獸醫院和專科診所而言更是如此。

此外，全球寵物飼養量的成長，尤其是在都市區和中等收入家庭中，推動了對獸醫護理和個人化治療需求的成長。同時，寵物越來越被視為家庭成員，導致診斷、預防保健和特殊治療方面的支出增加。因此，處方藥為獸醫主導的靈活解決方案提供了保障，尤其適用於慢性病、疼痛管理和老年相關疾病，而這些情況下，市面上常見的標準產品並不適用。此外，在北美、西歐和亞太地區，由於可支配收入的增加和寵物保險覆蓋範圍的擴大，獸醫支出持續成長。在美國，寵物飼養多樣化的趨勢進一步加劇了對物種特異性客製化處方藥的需求。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：市場波動因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 定價模型分析
  • 以使用者觀點的分析
  • 按主要品種和主要國家分類的動物數量估計（2025 年）
  • 市場分析工具
    • 波特五力分析
    • 基於SWOT分析的PESTEL分析
  • 關稅影響分析
    • 產業特定影響分析
    • 區域影響分析
    • 獸藥產業的戰略機會與風險
  • 非法銷售的動物製品的分析

第4章：獸藥市場：依給藥途徑分類的估算與趨勢分析

  • 獸藥市場：依給藥途徑分類的波動分析
  • 獸藥市場估算與預測：依給藥途徑分類（2021-2033 年）
  • 口服
  • 注射
  • 外用
  • 其他給藥途徑

第5章：獸藥市場：依動物種類分類的估算與趨勢分析

  • 獸藥市場：以動物種類分類的波動分析
  • 動物藥品市場估算與預測：按動物種類分類（2021-2033 年）
  • 伴侶動物
    • 狗
    • 貓
    • 其他
  • 家畜

第6章：獸藥市場：依產品類別分類的估算與趨勢分析

  • 獸藥市場：依產品類別分類的波動分析
  • 獸藥市場估算與預測：依產品分類（2021-2033 年）
  • 抗感染藥物
  • 抗發炎藥
  • 荷爾蒙及其替代品
  • 中樞神經系統藥物
  • 其他產品

第7章：獸藥市場：依劑型分類的估算與趨勢分析

  • 獸藥市場：以劑型分類的波動分析
  • 動物藥品市場估算與預測：依劑型分類（2021-2033 年）
  • 懸浮液
  • 解決方案
  • 膠囊和片劑
  • 其他

第8章：獸藥市場：區域估算與趨勢分析

  • 市場概覽：按地區
  • 市場佔有率分析：按地區分類（2025 年和 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 參與企業的分類
    • 市場領導
    • 新興企業
  • 市場佔有率/評估分析：熱力圖分析（2025 年）
  • 公司簡介
    • WEDGEWOOD PHARMACY
    • Vimian
    • Pharmaca
    • Akina Animal Health
    • Triangle Compounding
    • Davis Island Pharmacy and Compounding Lab
    • Custom Med Compounding Pharmacy
    • Central Compounding Center South
    • Wellness Pharmacy of Cary
    • Miller's Pharmacy
Product Code: GVR-4-68040-040-6

Animal Drug Compounding Market Summary

The global animal drug compounding market size was estimated at USD 1.68 billion in 2025 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. The market is advancing due to increasing demand for personalized veterinary therapies, shortages and discontinuation of commercial veterinary drugs and rising pet ownership and veterinary spending.

Rising complexity in veterinary care is driving demand for personalized drug formulations customized to diverse animal needs. The standardized medications often fail to provide precise dosing, suitable delivery routes, or acceptable palatability. Besides this, compounding enables veterinarians to adjust strength, formulation, excipients, and flavor, improving compliance and therapeutic outcomes. In addition, personalized therapies are particularly important for small mammals, geriatric animals, and chronic cases requiring long-term treatment. In addition, compounded drugs can be prepared as flavored suspensions, micro-dosed capsules, or transdermal gels to match species-specific requirements.

In addition, ongoing supply disruptions and discontinuation of veterinary drugs are increasing reliance on compounding to maintain continuity of care. The market withdrawals due to limited demand, manufacturing challenges, or regulatory changes often leave treatment gaps, particularly for niche species and specialized conditions. Besides this, veterinary compounding enables pharmacists to recreate discontinued medications or prepare therapeutic alternatives, ensuring uninterrupted access to essential therapies. This is especially critical for chronic, geriatric, and specialty treatments with limited commercial substitutes. In addition, growing supply chain volatility, raw material shortages, and shifting manufacturing priorities have made compounding an indispensable support system, particularly for rural veterinary practices and specialty clinics facing constrained drug availability.

Furthermore, rising global pet ownership, particularly among urban and middle-income households, is driving increased demand for veterinary care and personalized treatments. Besides this, pets are regarded as family members, encouraging higher spending on diagnostics, preventive care, and specialized therapies. Thus, compounded medications provide flexible, veterinarian-directed solutions when standard commercial products are unsuitable, especially for chronic diseases, pain management, and geriatric conditions. In addition, veterinary spending continues to grow across North America, Western Europe, and Asia Pacific, supported by rising disposable incomes and expanding pet insurance coverage. In the U.S., widespread pet ownership across multiple species further strengthens demand for customized, species-specific compounded formulations.

Global Animal Drug Compounding Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal drug compounding market report based on product, animal, route of administration, dosage form, and region:

  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
  • Topical
  • Other Routes
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Companion Animals
    • Dogs
    • Cats
    • Others
  • Livestock Animals
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Anti-infective Agents
  • Anti-inflammatory Agents
  • Hormones & Substitutes
  • CNS Agents
  • Other Products
  • Dosage Form Outlook (Revenue, USD Million, 2021 - 2033)
  • Suspensions
  • Solutions
  • Capsules & Tablets
  • Others
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Route of Administration
    • 1.2.2. Product
    • 1.2.3. Animal
    • 1.2.4. Dosage Form
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3 Volume-Pricing Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Personalized Veterinary Therapies
      • 3.2.1.2. Shortages And Discontinuation of Commercial Veterinary Drugs
      • 3.2.1.3. Rising Pet Ownership and Veterinary Spending
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of Standardized Regulatory Oversight
      • 3.2.2.2. High Cost and Limited Accessibility of Compounded Medications
    • 3.2.3. Market Opportunity Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. User Perspective Analysis
  • 3.5. Estimated Animal Population by Key Species & Key Countries, 2025
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis
  • 3.7. Tariff Impact Analysis
    • 3.7.1. Sector Impact Analysis
    • 3.7.2. Geographical Impact Analysis
    • 3.7.3. Strategic Opportunities & Risk for the Animal Drug Compounding Sector
  • 3.8. Illegally Marketed Veterinary Drug Compounding Analysis

Chapter 4. Animal Drug Compounding Market: By Route of Administration Estimates & Trend Analysis

  • 4.1. Animal Drug Compounding Market, By Route of Administration: Segment Dashboard
  • 4.2. Animal Drug Compounding Market, By Route of Administration Movement Analysis
  • 4.3. Animal Drug Compounding Market Estimates & Forecasts, by Route of Administration, 2021 to 2033 (USD Million)
  • 4.4. Oral
    • 4.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Injectable
    • 4.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Topical
    • 4.6.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Other Routes
    • 4.7.1. Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Animal Drug Compounding Market: By Animal Estimates & Trend Analysis

  • 5.1. Animal Drug Compounding Market, By Animal: Segment Dashboard
  • 5.2. Animal Drug Compounding Market, By Animal Movement Analysis
  • 5.3. Animal Drug Compounding Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Companion Animals
    • 5.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Dogs
      • 5.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Cats
      • 5.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Livestock Animals
    • 5.5.1. Livestock Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Animal Drug Compounding Market: By Product Estimates & Trend Analysis

  • 6.1. Animal Drug Compounding Market, By Product: Segment Dashboard
  • 6.2. Animal Drug Compounding Market, By Product Movement Analysis
  • 6.3. Animal Drug Compounding Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 6.4. Anti-infective Agents
    • 6.4.1. Anti-infective Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Anti-inflammatory Agents
    • 6.5.1. Anti-inflammatory Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Hormones & Substitutes
    • 6.6.1. Hormones & Substitutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. CNS Agents
    • 6.7.1. CNS Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Other Products
    • 6.8.1. Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Animal Drug Compounding Market: By Dosage Form Estimates & Trend Analysis

  • 7.1. Animal Drug Compounding Market, By Dosage Form: Segment Dashboard
  • 7.2. Animal Drug Compounding Market, By Dosage Form Movement Analysis
  • 7.3. Animal Drug Compounding Market Estimates & Forecasts, by Dosage Form, 2021 to 2033 (USD Million)
  • 7.4. Suspensions
    • 7.4.1. Suspensions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Solutions
    • 7.5.1. Solutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Capsules & Tablets
    • 7.6.1. Capsules & Tablets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Animal Drug Compounding Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. WEDGEWOOD PHARMACY
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Vimian
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Pharmaca
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Akina Animal Health
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Triangle Compounding
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Davis Island Pharmacy and Compounding Lab
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Custom Med Compounding Pharmacy
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Central Compounding Center South
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Wellness Pharmacy of Cary
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Miller's Pharmacy
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 6 Global Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 7 North America Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 9 North America Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 10 North America Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 11 North America Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 12 U.S. Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 13 U.S.Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 14 U.S.Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 15 U.S. Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 16 Canada Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 17 Canada Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 18 Canada Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 19 Canada Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 20 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 21 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 22 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 23 Mexico Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 24 Europe Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 26 Europe Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 27 Europe Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 28 Europe Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 29 UK Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 30 UK Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 31 UK Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 32 UK Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 33 Germany Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 34 Germany Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 35 Germany Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 36 Germany Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 37 France Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 38 France Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 39 France Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 40 France Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 41 Italy Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 42 Italy Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 43 Italy Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 44 Italy Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 45 Spain Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 46 Spain Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 47 Spain Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 48 Spain Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 49 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 50 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 51 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 52 Denmark Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 53 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 54 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 55 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 56 Sweden Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 57 Norway Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 58 Norway Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 59 Norway Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 60 Norway Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 66 Japan Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 67 Japan Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 68 Japan Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 69 Japan Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 70 China Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 71 China Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 72 China Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 73 China Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 74 India Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 75 India Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 76 India Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 77 India Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 78 Australia Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 79 Australia Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 80 Australia Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 81 Australia Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 82 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 83 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 84 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 85 Thailand Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 86 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 87 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 88 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 89 South Korea Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 90 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 92 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 93 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 94 Latin America Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 95 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 96 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 97 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 98 Brazil Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 99 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 100 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 101 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 102 Argentina Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 108 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 109 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 110 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 111 South Africa Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 112 UAE Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 113 UAE Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 114 UAE Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 115 UAE Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 117 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 124 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 125 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 126 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 127 Qatar Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)
  • Table 128 Oman Animal Drug Compounding Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 129 Oman Animal Drug Compounding Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 130 Oman Animal Drug Compounding Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 131 Oman Animal Drug Compounding Market Estimates and Forecasts, by Dosage Form, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-Up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2025 (USD Billion)
  • Fig. 16 Animal Drug Compounding Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Animal Drug Compounding Market: Product Outlook and Key Takeaways
  • Fig. 20 Animal Drug Compounding Market: Product Movement Analysis
  • Fig. 21 Anti-infective Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Anti-inflammatory Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Hormones & Substitutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 CNS Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Animal Drug Compounding Market: Animal Outlook and Key Takeaways
  • Fig. 27 Animal Drug Compounding Market: Animal Movement Analysis
  • Fig. 28 Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Livestock Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Animal Drug Compounding Market: Route of Administration Outlook and Key Takeaways
  • Fig. 34 Animal Drug Compounding Market: Route of Administration Movement Analysis
  • Fig. 35 Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Animal Drug Compounding Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 40 Animal Drug Compounding Market: Distribution Channel Movement Analysis
  • Fig. 41 Suspensions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Solutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Capsules & Tablets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America Animal Drug Compounding Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Europe Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Latin America Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 MEA Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Qatar Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Oman Animal Drug Compounding Market Estimates and Forecasts, 2021 - 2033 (USD Million)